GLP-1 Protocol vs Vida Health: Why Food-Based Nutrition Wins
2026-09-14
The Growing Gap in GLP-1 Care: Why Medication Alone Isn't Enough Millions of people are now taking GLP-1 medications like Ozempic and Wegovy for weight management and metabolic health. These medications work remarkably well at suppressing appetite, but they create an unintended problem: people eat significantly less while their nutritional needs remain the same or increase. When appetite drops, so does food intake. That's the medication doing its job. But less food means less protein, fewer micronutrients, and often inadequate fiber. We see patients experiencing muscle loss, nutrient deficiencies, and digestive issues within weeks of starting a GLP-1 prescription. They're losing weight, yes, but they're losing muscle alongside fat. The medication gap is real. Healthcare providers prescribe the drug but rarely provide structured nutritional support designed specifically for reduced-appetite eating. Patients are left to figure out how to eat well on their own, often defaulting to whatever fits their smaller appetite, not what their body actually needs. This is where the distinction between pharmaceutical support and nutritional support becomes critical. Medication addresses one side